Peptide Therapeutics Market Size And Share

  • Report Code : TIPRE00003793
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Peptide Therapeutics Market Size, Scope, and Share by 2031

Buy Now

Peptide Therapeutics Market Report Peptide Therapeutics Market Scope and Analysis Peptide Therapeutics Market Size and Share

Peptide Therapeutics Market: Strategic Insights

Peptide Therapeutics Market

  • CAGR (2023 - 2031)
    11.5%
  • Market Size 2023
    US$ 29.35 Billion
  • Market Size 2031
    US$ 73.63 Billion

Market Dynamics

GROWTH DRIVERS
  • Growing Investments on Peptide Therapeutics
FUTURE TRENDS
  • Emphasis on Automatic Peptide Synthesis
OPPORTUNITIES
  • Operational Limitations of Peptides

Key Players

  • Eli Lilly and Company
  • Amgen Inc
  • Teva Pharmaceutical Industries Ltd
  • Lonza
  • Sanofi
  • Bristol Myers Squibb Company
  • GlaxoSmithKline plc
  • AstraZeneca
  • Pfizer Inc
  • Novo Nordisk

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Type
  • Generic
  • Innovative
Route of Administration
  • Parenteral
  • Oral
  • Mucosal
  • Pulmonary
Synthesis Technology
  • Solid Phase Peptide Synthesis
  • Liquid Phase Peptide Synthesis
  • Hybrid Technology
Application
  • Cancer
  • Cardiovascular Disorder
  • Metabolic Disorder
  • Respiratory Disorder
  • Pain MAnagement
  • Dermatology